S
Skinsfan1229
Guest
http://www.ccfa.org/reuters/infliximabhospital?msource=HQ0712DMENWS&tr=y&auid=2204398
-Treatment with infliximab (Remicade) can reduce the average number of hospitalizations per year for ulcerative colitis by about 50%, according to study findings presented this week at the American College of Gastroenterology meeting.
-Treatment with infliximab (Remicade) can reduce the average number of hospitalizations per year for ulcerative colitis by about 50%, according to study findings presented this week at the American College of Gastroenterology meeting.